Molecular modeling of the oxidized form of nuclear factor-?B suggests a mechanism for redox regulation of DNA binding and transcriptional activation by NC DOCKS at The University of North Carolina at Greensboro & Taylor, Ethan W
Molecular modeling of the oxidized form of nuclear factor-κB suggests a mechanism for 
redox regulation of DNA binding and transcriptional activation 
 
By: Vasu Chandrasekaran and Ethan Will Taylor 
 
Vasu Chandrasekaran and Ethan Will Taylor. Molecular modeling of the oxidized form of 
nuclear factor-κB suggests a mechanism for redox regulation of DNA binding and transcriptional 
activation. Journal of Molecular Graphics and Modelling. Volume 26, Issue 5, January 2008, 
Pages 861-867. https://doi.org/10.1016/j.jmgm.2007.05.007 
 
***© 2007 Elsevier Inc. Reprinted with permission. This version of the document is not the 
version of record. *** 
 
 This work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License. 
 
Abstract: 
 
NF-κB is an important transcriptional regulator of numerous cellular genes, as well as viruses 
such as HIV-1. Oxidative stimuli in the cytosol are associated with nuclear translocation of NF-
κB, whereas in the nucleus, reductive activation by thioredoxin is required for NF-κB to bind to 
DNA and activate target genes. Experimental structures of the reduced form of NF-κB bound to 
its DNA targets are available, from which we have modeled the oxidized form of NF-κB 
homodimer by removal of bound DNA, and modification via a hinge movement of a linker 
between the dimerization and DNA-binding domains of each subunit. These torsional motions 
enabled the formation of an inter-subunit disulfide bond between the Cys62 residues of each 
monomer; the resulting structure was refined using molecular dynamics simulation. The final 
model of oxidized, disulfide-bridged NF-κB is more compact than the open, reduced form. This 
may facilitate its nuclear translocation through small pores in the nuclear envelope, in response 
to oxidative stimuli in the cytosol. Furthermore, the inter-subunit disulfide blocks DNA from 
entering the active site of the oxidized dimer, explaining why subsequent reduction to the thiol 
form in the nucleus is essential for DNA binding and transcriptional activation to occur. 
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Article: 
 
1. Introduction 
 
Nuclear factor-κB (NF-κB) is a latent, primary cellular transcription factor that regulates the 
expression of a wide variety of cellular genes, particularly those involved in host 
defense [1], [2], [3]. It plays a role not only as an evolutionarily conserved coordinating element 
in an organism's response to situations of infection, stress and injury, but also as an activator of a 
number of viral genes including those of HIV-1 [4]. While NF-κB acts as the central mediator of 
immune response in many cells, multiple families of viruses promote their replication, prevent 
virus-induced apoptosis and mediate the immune response to the invading pathogen by activating 
NF-κB [5], [6]. Thus the target genes under the regulation of NF-κB include a variety of cellular 
as well as viral genes. 
 
NF-κB is composed of homo- or heterodimers of different subunits, which are members of a 
family of structurally related proteins (Rel/NF-κB proteins). Five different Rel proteins have 
been identified so far: p50, p52, p65, RelB, and c-Rel. Members of the Rel/NF-κB protein family 
are characterized by the presence of a Rel Homology Domain (RHD), which contains a nuclear 
localization sequence and is involved in sequence-specific DNA binding, dimerization and 
interaction with inhibitory I-κB proteins [7], [8]. NF-κB predominantly exists as a heterodimer of 
p50/p65 subunits in the cytoplasm, although p50 homodimers are also commonly observed. Each 
subunit of the dimer consists of two major domains. The DNA-binding domain, consisting of 
180 amino acids at the amino-terminal end of the molecule, is responsible for base-specific DNA 
contacts, whereas the carboxyl-terminal domain of approximately 100 residues mediates 
dimerization, I-κB binding, and nuclear targeting via a nuclear localization sequence (NLS). The 
NLS is a cluster of basic amino acid residues, responsible for targeting the molecule into the 
nucleus [9], [10]. A flexible short linker of about 10 amino acids connects the DNA-binding and 
dimerization domains. 
 
In unstimulated cells, NF-κB dimers are retained in the cytosol in an inactive form as a 
consequence of their association with members of another family of proteins called I-κB 
(inhibitors of κB) [11], [12], [13]. In response to a variety of stimuli including physical and 
chemical stresses, cytokines, reactive oxygen intermediates (ROI) [14] and ultraviolet light, the 
latent cytoplasmic NF-κB/I-κB complex is activated by the multisubunit I-κB kinase (IKK) 
complex [15], [16]. The IKK complex causes proteolytic degradation [17] of I-κB through 
sequence-specific phosphorylation and ubiquitination of the I-κB molecule [18], [19], [20]. 
 
A key regulator of NF-κB is the cellular reducing catalyst, thioredoxin (Trx). Trx is a small 
endogenous molecule having a characteristic CXXC active site amino acid sequence, Cys-Gly-
Pro-Cys, in which the two cysteine residues form a redox center with the ability to reduce 
disulfide bonds [21]. Trx plays dual and opposing roles in the regulation of NF-κB. Via its 
antioxidant effects, Trx can suppress NF-κB activation in the cytoplasm, by interfering with the 
signal to I-κB kinases and thereby blocking the degradation of I-κB. In contrast, in the nucleus, 
reduction by Trx enhances NF-κB-dependent transcription, by enabling its ability to bind to 
DNA [22], [23]. Thus, transcriptional activation via NF-κB can be considered as two distinct 
steps with respect to the cellular compartment, with Trx playing distinct and opposed roles in the 
cytoplasm and in the cell nucleus. Activation and regulation of the NF-κB complex is thus a 
redox-sensitive process dependent on the activity of reducing proteins like Trx [24], [25]. 
 
In the cytoplasm, ROI mediate the degradation and release of I-κB from NF-κB, and in those 
oxidizing conditions, the reactive SH groups in NF-κB would be oxidized. The p50 subunit of 
NF-κB has seven cysteine residues at positions 62, 88, 119, 124, 162, 262 and 273. Among 
these, the DNA-binding loop of NF-κB contains a characteristic sequence motif with a cysteine 
(Cys62) and three arginine residues. These cysteine residues in each of the two subunits are 
susceptible to oxidation. In order for NF-κB to bind to DNA, it is necessary for these cysteine 
residues to be in the reduced state [26]. Studies have shown that the DNA-binding activity of p50 
correlates well with the redox states of Cys62, and that Trx regulates the DNA-binding activity 
of NF-κB by reduction of a disulfide bond involving Cys 62 [27]. The role of Cys62 of NF-κB as 
a specific target of Trx is also supported by an NMR structure of a small NF-κB peptide 
spanning this cysteine, covalently bound to the active site of Trx via a disulfide bond [28]. Thus, 
the oxidized form of Cys62 in NF-κB that is relevant for the mechanism of redox regulation of 
DNA binding is a disulfide, as opposed to other possible oxidation products of cysteine—and the 
most viable candidate for Cys62 to pair with is the corresponding cysteine residue on the other 
subunit of NF-κB. 
 
Despite extensive information available regarding the structure of NF-κB and the regulation of 
its signaling, there is still limited understanding of the in vivo dynamics of this pathway. 
Although it is has been established that NF-κB must be reduced by Trx in the nucleus in order to 
bind to DNA [28], the precise structure of the oxidized form of NF-κB when it enters the nucleus 
is still not known. Thus, in order to understand how Trx recognizes and binds to NF-κB in the 
nucleus, reduces the disulfide bond and activates it for DNA binding, a structural model of the 
oxidized form of NF-κB would be highly desirable. The crystal structures available so far are of 
the reduced form of homodimeric and heterodimeric NF-κB complexes bound to their DNA 
targets [29], [30]. These crystal structures present a static picture of the transcription factor 
bound to DNA, whereas the structure of the oxidized form would provide an intermediate 
structure in this pathway and provide insights into the molecular mechanisms involved prior to 
transcriptional activation. Similarly, studies have suggested the importance of ROI in stimulating 
degradation of the NF-κB/I-κB complex [14], [31], but the ways in which ROI and redox-active 
cysteine residues may contribute to the nuclear translocation of NF-κB are not fully understood. 
Since NF-κB dimers assume different conformations when bound to I-κB versus the free or 
DNA-bound structures, knowledge of the various intermediate structures is essential for 
understanding the dynamic nature of these molecules and the mechanistic details of the NF-κB 
pathway. To that end, in this study, computational modeling and molecular dynamics simulation 
techniques were applied to the existing experimental structural information to develop a 
preliminary structural model of the oxidized form of NF-κB. 
 
2. Methods 
 
2.1. Model building 
 
The crystal structure of the transcription factor NF-κB p50 homodimer bound to a kappa B 
sequence of DNA (PDB entry: 1NFK) [30] was used as the starting structure for building the 
oxidized model. After deleting the bound DNA helix from the dimer, the structure was examined 
to identify the peptide region that confers flexibility to the dimer and causes the movement of the 
two subunits. Analysis of the protein structure showed that the peptide linker connecting the 
amino and carboxyl-terminal domains of NF-κB could be involved in a hinge movement that 
produces a change in the orientation of the DNA-binding domains of the two subunits, bringing 
the two Cys62 residues within disulfide bonding distance (Fig. 1). 
 
Fig. 1. Three-dimensional structure of NF-κB p50 homodimer (PDB code: 1NFK) with the DNA 
removed. The DNA-binding domain and the dimerization domain are shown in red and blue, 
respectively; the residues (Ala242-Asn244) in the linker region that contribute to the hinge 
movement are shown in green. 
 
Subsequently, in an effort to model the oxidized, disulfide-bridged structure of NF-κB, the 
backbone torsion angles of the linker region were modified to achieve the desired conformation. 
Any reasonable mechanism of conformational change would involve low energy expenditure, 
and would therefore occur through minimum torsional angle modifications to the backbone. 
Keeping this in mind, systematic search of torsional angle space in the linker region pointed to 
residues Ala242-Asn244 (1NFK numbering) that produced significant conformational change to 
the protein structure upon small torsional modifications. Since the linker region was relatively 
unconstrained by packing and was not part of an α-helix or a β-sheet, the hinge movement did 
not impose any restrictions on hydrogen bonding. The only structural constraint was that the 
torsion angles remain in the allowed regions of the Ramachandran plot. Two torsions, 
the ψ and ω angles around Pro243, were modified by 30° and 12°, respectively to produce a 
conformation with minimum expenditure of energy and having the least steric hindrance. This 
localized torsion angle modification induced a large movement about the hinge thereby bringing 
the Cys59 residues (1NFK numbering) of the two subunits closer to each other, for disulfide 
bonding. The rest of the protein however rotated as a rigid body, with the axis of rotation passing 
through the hinge region (Fig. 2, Fig. 3). 
 
 
Fig. 2. Superposition of the NF-κB dimers before (green) and after (cyan) hinge movement. 
Hinge movement through torsion angle modification brings the DNA-binding domains closer, 
while the dimerization domain is unaffected. 
 
 
Fig. 3. Close-up view of the hinge region residues before (blue) and after (red) torsional 
modification. The ψ and ω angles around Pro243 were modified by 30° and 12°, respectively. 
 
2.2. Model refinement 
 
Molecular dynamics (MD) simulation was carried out after hinge movement, in order to remove 
unfavorable steric interactions and refine the positions of side chains in the modeled oxidized 
structure. To pre-condition the modeled structure, energy minimization using the Kollman all-
atom force field [32] as implemented in SYBYL 7.0 (Tripos Inc., Louis, MO) was performed for 
2000 steps of steepest descent and 3000 steps of conjugate gradient minimization. A distance-
dependent dielectric function was used with the dielectric constant set to r (the distance in 
angstroms between atom pairs) and the non-bonded cutoff was set to 8 Å. The resulting structure 
was used as the starting structure for the MD simulation, performed using AMBER 7.0 
molecular simulation package [33]. A complete MD study of the NF-κB dimer requires 
simulation performed when the protein is adequately solvated. However, due to the large size of 
the system after adding water molecules, it was decided to simplify the model of the protein so 
that computing resources could be conserved. Also, the sampling of configurational space for the 
whole protein is too slow to allow sufficient sampling in the available time. But when structural 
restraints are used to restrict atomic freedom, the required sampling is less extensive. Therefore 
the simulation was carried out in vacuo with a simple distant-dependent dielectric solvation 
model, using the BELLY option, in which only the atoms of residues within 30 Å of the disulfide 
bridge were allowed freedom of motion during the course of the MD trajectory, while the 
residues outside that radius were restrained. At physiological pH, the starting structure was 
positively charged; thus, in order to make the simulation system electrically neutral, counter ions 
(Cl−) were added using the LEAP module. As a preparatory step for the simulation a 1000-step 
minimization was run using a combination of steepest descent and conjugate gradient method to 
relax the chloride ions and to remove the strong initial forces due to collisions generated by the 
ions insertion process. A 3 ns simulation was performed under constant pressure conditions using 
the parm99 force field to describe the interactions between the protein atoms [34]. As in the 
minimization, the non-bonded cutoff for electrostatic and van der Waals was set to 8 Å and a 
distance-dependent dielectric function with the dielectric constant set to r was used. The 
simulation was carried out using a 2 fs time step for a total simulation time of 3 ns. The energy 
profile was then analyzed to compare the structures of the reduced and oxidized models. 
 
3. Results and discussion 
 
3.1. Effect of torsion angle modifications 
 
The large conformational change occurring in NF-κB upon torsional modification can be 
described as a rigid body movement of one domain in relation to the other with very little change 
to the internal conformation of either domain. After superposition of the backbone atoms of 
dimerization domains of the reduced and oxidized structures, the RMS deviation was only 
0.16 Å in the dimerization domain (reflecting some minor changes during energy minimization), 
whereas it was 5.86 Å for the DNA-binding domain, resulting from a change in the relative 
orientation of this domain relative to the (fixed) dimerization domain. Thus, this number 
(5.86 Å) represents the mean atomic displacement for atoms in the DNA-binding domain after 
the hinge motion. The large relative movement of the two subunits is a consequence of small 
rotations of two backbone torsion angles in the connecting strand. These relatively small changes 
to the backbone torsions yielded a significant change in the relative orientation of each of the 
subunits, causing an en bloc movement of entire domains. At the same time, these torsional 
changes kept the secondary structural features intact. The distance between sulfur atoms of the 
Cys62 residues in the two subunits was reduced from 19.9 Å (SG–SG) in the starting crystal 
structure to 3.8 Å after the torsional modifications alone, prior to minimization and dynamics, 
after which the S–S distance was reduced to 2.3 Å, a typical S–S bonding distance. The 
transcription factor undergoes a dynamic change between the open and closed conformation due 
to the flexible linker region between the DNA-binding and the dimerization domains. This kind 
of behavior does not appear to be specific for NF-κB alone: a similar opening–closing movement 
of domains has been observed in many binding proteins and the peptide region connecting the 
domains is primarily responsible for the conformational change [35]. It could be argued that the 
domain movements would involve a more complex mechanism than simple backbone torsional 
modification to produce such a large change in conformation. However, this hinge movement is 
consistent with domain movements observed in several other proteins, indicating that the 
flexibility of protein structures is important for their catalytic activity [36], [37]. 
 
In fact earlier crystallographic studies have shown that in NF-κB, the p65 subunit is remarkably 
flexible and adopts a different conformation upon binding to I-κBα. Compared to its DNA-bound 
open conformation, the I-κBα-bound p65 amino-terminal domain rotates almost 180° and 
translates 38 Å towards its carboxyl-terminal domain [12]. This movement is also entirely due to 
the flexible peptide linker connecting the DNA-binding and dimerization domains. These large 
relative domain movements, as observed in many protein structures, provide examples of protein 
flexibility. 
 
It is also notable that a new dimer interface is formed in the region of contact around the new 
disulfide bridge. This is actually a fairly limited area of contact, local to the two cysteine residues 
(as seen in Fig. 2, Fig. 6b). The NF-κB dimer is more than adequately held together by its 
dimerization domains, and this new connection between the DNA-binding domains in the 
oxidized form probably serves primarily to block DNA entry, serving as the “off” switch for NF-
κB, and therefore must be easily reversible on reduction by Trx. Thus, an excessively strong 
contact here could be counterproductive. The extent of the new contact surface was calculated 
(from the decrease in total solvent-exposed surface) as being at most 100 Å2 per monomer, 
which is not a large contact area. The details and energy contributions to this contact are 
discussed further in the following section. 
 
3.2. Refinement using molecular dynamics simulation 
 
A number of bad steric contacts are typically introduced during torsion angle modification, so to 
eliminate these bad contacts and establish an accurate structural model, a MD simulation was 
carried out. In our simulation, the primary focus was on the movement of the DNA-binding 
domain; since NF-κB is a large protein with 624 amino acids, the objective was to simulate a 
truncated portion of the molecule, which would allow for more efficient use of computing time. 
Therefore, we used a model in which only the atoms within 30 Å distance from the disulfide 
bridge were included in the simulation. Bad steric contacts were removed and side chain rotamer 
distributions were improved after a 3 ns simulation. The Ramachandran plot of the backbone 
angles for the oxidized model was computed with PROCHECK to locate any abnormal peptide 
linkages or other unlikely bond angles [38]. Examination of the plot (Fig. 4) shows that the 
residues fall in the allowed regions of phi–psi space and the model is structurally refined after the 
MD simulation. 
 
 
Fig. 4. Ramachandran plot for the oxidized form of NF-κB. 
 
After the structural refinements, energies were calculated to see if there is a substantial energy 
penalty for forming the disulfide-bonded oxidized state of NF-κB. On the contrary, it was 
observed that the resulting oxidized structure was actually more energetically favorable than the 
reduced structure, by around 200 kcal/mol (although this is only a qualitative result considering 
the lack of explicit solvation in the calculations). This result nonetheless supports the hypothesis 
that the oxidized form is at least as energetically favorable as the reduced form, suggesting that 
oxidation does not impose any energy penalty as a prerequisite for nuclear translocation of NF-
κB. We analyzed the energy contributions to the relative stabilization of the oxidized form, and 
87% of the difference is contributed by electrostatic terms. However, the new contact area is 
small (∼100 Å2 per monomer) and there are no explicit salt bridges formed, so, in addition to the 
formation of the covalent S–S bond, we conclude that this interaction is driven by overall 
electrostatic complementarity operating at medium distances. 
 
3.3. Size of the molecule and ability to bind to DNA 
 
NF-κB molecules act as substrates for the nuclear transport receptors, importin α3 and α4, and 
are delivered to the nucleus, where they stimulate transcription of genes. Following I-κB 
degradation, the peptide region containing the NLS is exposed in NF-κB and the nuclear import 
mechanism kicks in. NF-κB is translocated into the nucleus through the nuclear pores by 
association with the importin complex [39]. Studies on the influence of cargo size for molecules 
that are transported into the nucleus through this mechanism have shown that the rate of 
transportation is inversely proportional to the molecular size of the cargo. Small cargo sizes 
result in easier transportation, with increased rates as compared to larger cargo sizes. Analysis of 
the size of the modeled oxidized NF-κB structure shows that it is significantly more compact 
than the reduced form, which could facilitate its entry through nuclear pores (Fig. 5). Using the 
program Deepview [40], the size of the smallest box that can enclose the entire molecule or the 
molecular volume was calculated for both the structures and it was found that the smallest box 
capable of containing the oxidized structure had a volume that was 5032 Å3 smaller than that 
required to contain the reduced form. This appreciable reduction in volume is expected to 
improve its ability to pass through the nuclear pore. We hypothesize that oxidation in the cytosol 
facilitates nuclear translocation of NF-κB, due to the more compact shape of the oxidized form. 
However, it is difficult from this study to determine unequivocally the extent to which the size 
reduction may help in the nuclear import mechanism. 
 
 
Fig. 5. Space-filling models of the oxidized (red) and reduced (blue) forms of NF-κB. The 
oxidized form is significantly more compact than the reduced form, which may facilitate its 
nuclear entry. 
 
The observed decrease in volume from the surface and core of the protein shows that the volume 
of the DNA-binding cleft is also reduced in the oxidized form, making it impossible for DNA to 
enter and bind to NF-κB, as a result of steric hindrance. It is exactly what is expected from the 
convergence of two subunits, resulting in a decrease in the volume of the binding pocket, making 
it difficult for DNA to interact with the residues in the pocket and in fact making it impossible 
for DNA to enter the binding cleft when the inter-subunit disulfide bridge is present. This 
demonstrates the need for Trx to reduce the disulfide bond in order to enable DNA binding and 
transcriptional activation. The oxidized structure thus highlights the intricate and multi-faceted 
relationship between redox status and NF-κB activation, highlighting the importance of 
observations showing that NF-κB responds to different stimuli in the cytoplasm and in the cell 
nucleus. 
 
4. Conclusions 
 
Although it has been established that Trx regulates the DNA-binding activity of NF-κB through 
reduction of a disulfide bond involving Cys62 residues [26], no detailed structure of NF-κB in its 
oxidized form has been presented until now. Despite the relatively large number of crystal 
structures available for the bound conformations of NF-κB with the DNA or I-κB, there have 
been no structures available for the unbound conformation. In this study we have derived a 
model using computational modeling and simulation methods that describes the structure of NF-
κB in its oxidized state, prior to reductive activation by Trx (Fig. 2, Fig. 5, Fig. 6). Our model is 
consistent with previous reports showing that these critical cysteine residues need to be reduced 
by Trx in order for NF-κB to bind to DNA. 
 
 
Fig. 6. Comparison of the DNA-binding cleft of the reduced and oxidized forms (a) reduced 
form of NF-κB (PDB code 1NFK) with the bound DNA. The Cys62 (Cys59 in PDB file) 
residues in the two subunits are shown in yellow. (b) Modeled structure of the oxidized form of 
NF-κB showing the inter-subunit disulfide bond (in yellow). 
 
This model of the oxidized form of NF-κB indicates that the linker region that connects the 
dimerization and DNA-binding domains provides flexibility to the protein structure necessary for 
the relatively large movements upon oxidation and reduction. This connecting strand can readily 
act as a hinge between the two domains, providing conformational flexibility to the molecule. 
 
Also, it is known that disulfide bridges often play functional roles in proteins and studies have 
shown that the enzyme Trx acts as a regulatory switch of target proteins by reducing their 
disulfide bonds. The structural data from this study suggests that the disulfide bond formation 
that results in the closed conformation of the dimer is the form that must be targeted and 
recognized by Trx in order to be reduced so that it can bind to its cognate DNA target. After the 
Cys62 residues that are involved in disulfide bonding are reduced, the DNA-binding regions of 
the two subunits which were in contact with each other must move farther apart, opening the 
binding cleft. The DNA can then enter the cleft formed upon reduction of NF-κB, where it can 
be recognized and initiate the process of transcription. An accurate picture of the binding mode 
of Trx on oxidized NF-κB, and the dynamic trajectory of the reduction itself, are important goals 
for the next phase of modeling studies that are being undertaken in our laboratory. 
 
In conclusion, the model for the oxidized form of NF-κB proposed here provides structural 
explanations for questions that were not answered by previous experimental studies that showed 
NF-κB bound to either DNA or I-κB molecules. This snapshot of the oxidized form provides 
insight into an intermediate structure of the NF-κB activation pathway and also highlights the 
importance of redox signaling in controlling transcriptional activation. However, in different cell 
types under various conditions there may be not only different NF-κB dimers, but a number of 
potential interactions between I-κB, DNA, NF-κB species and Trx contributing to the complexity 
of the system. This complexity highlights the need for an integrated approach, in which modeling 
is used to extrapolate between the available experimental structures. Not only additional 
modeling studies, but also much further experimental work including NMR studies, will be 
required to solve and confirm more of the intermediate structures, in order to better understand 
the dynamic nature of the NF-κB pathway. 
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